Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
NVIDIA
NVDA
|
$389M |
| 2 |
Boeing
BA
|
$376M |
| 3 |
Bank of America
BAC
|
$334M |
| 4 |
UnitedHealth
UNH
|
$330M |
| 5 |
Union Pacific
UNP
|
$280M |
Top Sells
| 1 |
CSX Corp
CSX
|
$554M |
| 2 |
Home Depot
HD
|
$344M |
| 3 |
Apple
AAPL
|
$342M |
| 4 |
Adobe
ADBE
|
$301M |
| 5 |
ATVI
Activision Blizzard Inc.
ATVI
|
$286M |
Sector Composition
| 1 | Technology | 23.78% |
| 2 | Healthcare | 15.26% |
| 3 | Financials | 14.17% |
| 4 | Industrials | 12.87% |
| 5 | Consumer Discretionary | 11.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
HealthEquity
HQY
$7.88B
| $197M | 0.11% |
2,627,474
-168,194
| -6% | -$12.6M |
|
227
Marsh & McLennan
MMC
$100B
| $197M | 0.11% |
2,402,400
-653,314
| -21% | -$53.6M |
|
228
Donaldson
DCI
$9.44B
| $197M | 0.11% |
4,360,680
+368,578
| +9% | +$16.6M |
|
229
Cboe Global Markets
CBOE
$24.3B
| $197M | 0.11% |
1,889,802
+109,034
| +6% | +$11.3M |
|
230
Crown Holdings
CCK
$11B
| $197M | 0.11% |
4,392,496
-460,813
| -9% | -$20.6M |
|
|
ENV
231
DELISTED
ENVESTNET, INC.
ENV
| $196M | 0.11% |
3,575,547
-2,587
| -0.1% | -$142K |
|
232
Puma Biotechnology
PBYI
$253M
| $195M | 0.11% |
3,302,021
-1,180,285
| -26% | -$69.8M |
|
233
Valero Energy
VLO
$48.7B
| $195M | 0.11% |
1,757,883
+647,321
| +58% | +$71.7M |
|
234
Viatris
VTRS
$12.2B
| $195M | 0.11% |
5,389,463
+144,075
| +3% | +$5.21M |
|
|
ZEN
235
DELISTED
ZENDESK INC
ZEN
| $194M | 0.11% |
3,560,177
-1,030,952
| -22% | -$56.2M |
|
236
Teck Resources
TECK
$16.8B
| $193M | 0.11% |
7,561,492
+6,192,051
| +452% | +$158M |
|
237
Ligand Pharmaceuticals
LGND
$3.25B
| $192M | 0.11% |
1,486,143
+88,149
| +6% | +$11.4M |
|
238
Novartis
NVS
$251B
| $191M | 0.11% |
2,818,993
+687,282
| +32% | +$46.5M |
|
239
Hilton Worldwide
HLT
$64B
| $191M | 0.11% |
2,410,411
+1,315,274
| +120% | +$104M |
|
|
FNGN
240
DELISTED
Financial Engines, Inc.
FNGN
| $190M | 0.11% |
4,225,959
-70,803
| -2% | -$3.18M |
|
241
Hartford Financial Services
HIG
$37B
| $190M | 0.11% |
3,707,636
-554,414
| -13% | -$28.3M |
|
|
GBT
242
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $188M | 0.11% |
4,154,385
+452,843
| +12% | +$20.5M |
|
|
EQC
243
DELISTED
Equity Commonwealth
EQC
| $188M | 0.11% |
5,955,776
-16,415
| -0.3% | -$517K |
|
244
DXC Technology
DXC
$2.65B
| $181M | 0.1% |
2,241,278
-491,951
| -18% | -$39.7M |
|
245
Republic Services
RSG
$71.7B
| $180M | 0.1% |
2,631,068
-296,452
| -10% | -$20.3M |
|
|
ETFC
246
DELISTED
E*Trade Financial Corporation
ETFC
| $179M | 0.1% |
2,932,616
+460,318
| +19% | +$28.2M |
|
247
Insmed
INSM
$30.7B
| $176M | 0.1% |
7,454,938
+1,208,596
| +19% | +$28.6M |
|
248
Equity Lifestyle Properties
ELS
$12B
| $176M | 0.1% |
3,828,892
-241,676
| -6% | -$11.1M |
|
249
D.R. Horton
DHI
$54.2B
| $176M | 0.1% |
4,285,926
+1,111,840
| +35% | +$45.6M |
|
250
Roper Technologies
ROP
$55.8B
| $175M | 0.1% |
634,494
-90,427
| -12% | -$24.9M |
|